Two-Component Cluster Analysis of a Large Serodiagnostic Database for Specificity of Increases of IgG Antibodies against Pertussis Toxin in Paired Serum Samples and of Absolute Values in Single Serum Samples
Open Access
- 1 September 2012
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 19 (9) , 1452-1456
- https://doi.org/10.1128/cvi.00229-12
Abstract
Measuring IgG antibodies against pertussis toxin (IgG-Ptx) with an enzyme-linked immunosorbent assay (ELISA) can be used to diagnose pertussis infection; however, the cutoff points are not unanimously defined. To determine the diagnostic specificity of increases of IgG-Ptx in paired sera and of absolute values in single serum samples, we applied a two-component cluster analysis to serum samples of patients suspected for pertussis, whose sera had been submitted to a routine diagnostic laboratory between 2003 and 2009, and had been assayed with an in-house IgG-Ptx ELISA calibrated with the international FDA lot 3 IgG-Ptx reference serum. Children eligible for the acellular pertussis vaccination were excluded to avoid interference from a vaccine-induced IgG-Ptx rise. Binary distribution mixtures were fitted to the data. Receiver operating characteristic (ROC) curves were calculated for absolute values in single samples ( n = 14,452) and increases in paired samples ( n = 2,455). For both parameters, two subpopulations could be identified: a population with high reactivity (persons with pertussis infection) and a population with low reactivity (persons without pertussis infection). For absolute values in single samples, the area under the curve (AUC) of the ROC curve was 0.993 and the optimum cutoff (with the highest cumulative value of specificity plus sensitivity) was 67.7 IU/ml (95% confidence interval, 63.9 to 74.1; sensitivity, 96.4%; specificity, 95.7%). A previously determined diagnostic cutoff of 125 IU/ml was associated with a sensitivity of 88.1% and a specificity of 98.8%. For increases in paired sera, the AUC was 0.999 and the optimum cutoff was 3.1-fold (95% CI, 2.8 to 3.4; sensitivity, 99.6%; specificity, 99.2%). Given the methodology of this study, estimates of sensitivity probably are overrated (because pertussis patients without IgG-Ptx response are not detected), but estimates of specificities can be considered very accurate.Keywords
This publication has 38 references indexed in Scilit:
- Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected childrenVaccine, 2011
- Seroprevalence of Pertussis in the Netherlands: Evidence for Increased Circulation of Bordetella pertussisPLOS ONE, 2010
- What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratoriesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccineJournal of Medical Microbiology, 2010
- Pertussis Disease Burden in the Household: How to Protect Young InfantsClinical Infectious Diseases, 2010
- Characterization of Reference Materials for Human Antiserum to Pertussis Antigens by an International Collaborative StudyClinical and Vaccine Immunology, 2009
- Comparison of Serological and Real-Time PCR Assays To Diagnose Bordetella pertussis Infection in 2007Journal of Clinical Microbiology, 2008
- Immunity to Pertussis 5 Years after Booster Immunization during AdolescenceClinical Infectious Diseases, 2007
- Immune Responses and Antibody Decay after Immunization of Adolescents and Adults with an Acellular Pertussis Vaccine: The APERT StudyThe Journal of Infectious Diseases, 2004
- The Increasing Incidence of Pertussis in Massachusetts Adolescents and Adults, 1989–1998The Journal of Infectious Diseases, 2000